Expert Opinion on Biological Therapy, Volume 21, Issue 9 (2021)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Biological Therapy, Volume 21, Issue 9 (2021)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Volume 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Drug Evaluation

Article
The role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis
Jeffrey P Aldinger, Taylor Dobyns, Kent Lam & Joseph K Han
Pages: 1143-1149
Published online: 12 Aug 2021
AbstractforThe role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis | Full Text | References | PDF (335.5 KB) | EPUB
  • 385 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Lisocabtagene Maraleucel for the treatment of B-cell lymphoma
Chaitanya Iragavarapu & Gerhard Hildebrandt
Pages: 1151-1156
Published online: 28 Jun 2021
AbstractforLisocabtagene Maraleucel for the treatment of B-cell lymphoma | Full Text | References | PDF (1.1 MB) | EPUB
  • 530 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Pembrolizumab for the treatment of renal cell carcinoma
Carlo Di Bona, Viktoria Stühler, Steffen Rausch, Arnulf Stenzl & Jens Bedke
Pages: 1157-1164
Published online: 03 Jun 2021
AbstractforPembrolizumab for the treatment of renal cell carcinoma | Full Text | References | PDF (349.4 KB) | EPUB
  • 315 Views
  • 1 CrossRef citations
  • 0Altmetric

Review

Expert opinion paper on the treatment of hemophilia B with albutrepenonacog alfa
María Teresa Álvarez Román, Olga Benítez, Maria Isabel Canaro, María Fernanda López Fernández, Francisco J. López Jaime, José Mateo Arranz, Ramiro Núñez, Manuel Rodríguez López, Cristina Sierra Aisa & Victor Jiménez-Yuste
Pages: 1165-1171
Published online: 06 Jul 2021
AbstractforExpert opinion paper on the treatment of hemophilia B with albutrepenonacog alfa | Full Text | References | PDF (1 MB) | EPUB
  • 2841 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Immune checkpoint inhibition in COVID-19: risks and benefits
Parmida Sadat Pezeshki & Nima Rezaei
Pages: 1173-1179
Published online: 17 Feb 2021
AbstractforImmune checkpoint inhibition in COVID-19: risks and benefits | Full Text | References | PDF (860.3 KB) | EPUB
  • 2900 Views
  • 23 CrossRef citations
  • 0Altmetric
Enzyme replacement combinational therapy: effective treatments for mucopolysaccharidoses
Azam Safary, Hakimeh Moghaddas-Sani, Mostafa Akbarzadeh-Khiavi, Alireza Khabbazzi, Mohammad A. Rafi & Yadollah Omidi
Pages: 1181-1197
Published online: 11 Mar 2021
AbstractforEnzyme replacement combinational therapy: effective treatments for mucopolysaccharidoses | Full Text | References | PDF (3.9 MB) | EPUB
  • 287 Views
  • 3 CrossRef citations
  • 0Altmetric
Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer
Sara A. Collins, Ashish H. Shah, Derek Ostertag, Noriyuki Kasahara & Douglas J. Jolly
Pages: 1199-1214
Published online: 06 May 2021
AbstractforClinical development of retroviral replicating vector Toca 511 for gene therapy of cancer | Full Text | References | PDF (5.6 MB) | EPUB
  • 2686 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma
Viktoria Stühler, Steffen Rausch, Jan Moritz Maas, Arnulf Stenzl & Jens Bedke
Pages: 1215-1226
Published online: 27 Feb 2021
AbstractforCombination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma | Full Text | References | PDF (411.5 KB) | EPUB
  • 310 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Biologics in food allergy: up-to-date
Stefano Passanisi, Lucia Caminiti, Giuseppina Zirilli, Fortunato Lombardo, Giuseppe Crisafulli, Tommaso Aversa & Giovanni B Pajno
Pages: 1227-1235
Published online: 30 Mar 2021
AbstractforBiologics in food allergy: up-to-date | Full Text | References | PDF (580.2 KB) | EPUB
  • 453 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
A systematic review of immune checkpoint inhibitor-related neurological adverse events and association with anti-neuronal autoantibodies
Ayesha Salim, G Tapia Rico, A Shaikh & MP Brown
Pages: 1237-1251
Published online: 16 Apr 2021
AbstractforA systematic review of immune checkpoint inhibitor-related neurological adverse events and association with anti-neuronal autoantibodies | Full Text | References | PDF (2.6 MB) | EPUB
  • 463 Views
  • 3 CrossRef citations
  • 0Altmetric
Advanced clinical imaging for the evaluation of stem cell based therapies
Michail E. Klontzas, George A. Kakkos, Georgios Z. Papadakis, Kostas Marias & Apostolos H. Karantanas
Pages: 1253-1264
Published online: 23 Feb 2021
AbstractforAdvanced clinical imaging for the evaluation of stem cell based therapies | Full Text | References | PDF (2.4 MB) | EPUB
  • 94 Views
  • 5 CrossRef citations
  • 0Altmetric

Meta-analysis

Association between cumulative rATG induction doses and kidney graft outcomes and adverse effects in kidney transplant patients: a systematic review and meta-analysis
Keyhan Mohammadi, Behrouz Khajeh, Simin Dashti-Khavidaki & Sakineh Shab-bidar
Pages: 1265-1279
Published online: 04 Aug 2021
AbstractforAssociation between cumulative rATG induction doses and kidney graft outcomes and adverse effects in kidney transplant patients: a systematic review and meta-analysis | Full Text | References | PDF (13.3 MB) | EPUB | Supplemental
  • 297 Views
  • 1 CrossRef citations
  • 0Altmetric

Original Research

Article
The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database
Faizan Mazhar, Vera Battini, Michele Gringeri, Marco Pozzi, Giulia Mosini, Albaraa Mohammed N. Marran, Shahzad Akram, Robbert P. van Manen, Sonia Radice, Emilio Clementi & Carla Carnovale
Pages: 1281-1290
Published online: 07 Jul 2021
AbstractforThe impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database | Full Text | References | PDF (315.4 KB) | EPUB
  • 368 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy
Arianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini, Mauro Bavetta, Dario Graceffa, Claudio Bonifati, Franca Cantoresi, Sara Faleri, Domenico Giordano, Marco Mariani, Adriana Micheli, Gaia Moretta, Federico Pirro, Gianluca Pagnanelli, Vincenzo Panasiti, Alessia Provini, Antonio Richetta, Lidia Sacchelli, Luca Bianchi & Ketty Peris
Pages: 1291-1298
Published online: 18 Jul 2021
AbstractforPredictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy | Full Text | References | PDF (737.2 KB) | EPUB
  • 305 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy
M Galluzzo, G Caldarola, C De Simone, N Bernardini, G Moretta, S Pallotta, E Botti, E Campione, F Pirro, C. Potenza, L Bianchi & K Peris
Pages: 1299-1310
Published online: 28 Jun 2021
AbstractforUse of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy | Full Text | References | PDF (5.5 MB) | EPUB
  • 2216 Views
  • 13 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Understanding patient variability to biologic treatments in inflammatory bowel disease
Ahmad Z. Al Meslamani
Editorial | Published online: 26 May 2024
Free Access
Next-generation CD40 agonists for cancer immunotherapy
Hampus Andersson et al.
Review Article | Published online: 23 May 2024
Open Access
Non-TNF biologics and their biosimilars in rheumatoid arthritis
Tsz Ching Mok et al.
Review Article | Published online: 22 May 2024
Could siRNA therapeutics change the way we treat dyslipidemia?
Peter E. Penson et al.
Editorial | Published online: 22 May 2024
Free Access
View all latest articles